Safety and Efficacy Study of KAI-9803 to Treat Subjects With ST Elevation Myocardial Infarction [Heart Attack]
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- A.Michael Lincoff, MD
The Cleveland Clinic
Principal Investigator - Gregory Bell, MD
KAI Pharmaceuticals, Inc
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
126 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Bedford Park, Australia
- Facility name not stated
Boxhill, Australia
- Facility name not stated
Epping, Australia
- Facility name not stated
Fremantle, Australia
- Facility name not stated
Hobart, Australia
- Facility name not stated
Kogarah, Australia
- Facility name not stated
Liverpool, Australia
- Facility name not stated
Parkville, Australia
- Facility name not stated
Perth, Australia
- Facility name not stated
St Leonards, Australia
- Facility name not stated
Victoria, Australia
- Facility name not stated
Antwerp, Belgium
- Facility name not stated
Bonheiden, Belgium
- Facility name not stated
Brussels, Belgium
- Facility name not stated
Liège, Belgium
- Facility name not stated
Roeselare, Belgium
- Facility name not stated
Edmonton, Alberta, Canada
- Facility name not stated
Vancouver, British Columbia, Canada
- Facility name not stated
Hamilton, Ontario, Canada
- Facility name not stated
Kitchner, Ontario, Canada
- Facility name not stated
Newmarket, Ontario, Canada
- Facility name not stated
Toronta, Ontario, Canada
- Facility name not stated
Toronto, Ontario, Canada
- Facility name not stated
Montreal, Quebec, Canada
- Facility name not stated
Sainte-Foy, Quebec, Canada
- Facility name not stated
New Brunswick, Canada
- Facility name not stated
Brno, Czechia
- Facility name not stated
Hradec Králové, Czechia
- Facility name not stated
Karlovy Vary, Czechia
- Facility name not stated
Labem, Czechia
- Facility name not stated
Liberec, Czechia
- Facility name not stated
Olomouc, Czechia
- Facility name not stated
Ostrava, Czechia
- Facility name not stated
Pilsen, Czechia
- Facility name not stated
Prague, Czechia
- Facility name not stated
Zlín, Czechia
- Facility name not stated
Aalborg, Denmark
- Facility name not stated
Copenhagen, Denmark
- Facility name not stated
Hellerup, Denmark
- Facility name not stated
Odense, Denmark
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2008
- Primary completion
- 31 Jul 2010
- Completion
- 31 May 2011
- Last update posted
- 2 Sept 2011
- Registered enrollment
- 1,180
- Registry id
- NCT00785954
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.